Skip to main content
Carisma Therapeutics, Inc. (CARM)
OTCMKTS · Delayed Price · Currency is USD
0.0530
+0.0045 (9.28%)
At close: Dec 5, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY undefined FY undefined FY undefined FY undefined FY undefined
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Chimeric Antigen Receptor Macrophage and Monocyte Cell Therapy
19.63M
Log In
Log In
Log In
Log In
Chimeric Antigen Receptor Macrophage and Monocyte Cell Therapy Growth
31.59%
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY undefined FY undefined FY undefined FY undefined FY undefined
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
United States
19.63M
Log In
Log In
Log In
Log In
United States Growth
31.59%
Log In
Log In
Log In
Log In